Ms. Kamp is a Senior Associate, Executive Director Strategic Initiatives, Clinical Materials Services Unit (CMSU) in the Center for Human Experimental Therapeutics (CHET). Ms. Kamp received her Masters in Business Administration from the William E. Simon School of Business Administration from the University of Rochester, with a dual major in Finance and Operations Management in 1994. Ms. Kamp has more than 20 years experience in pharmaceutical based research, both commercial and academic. Ms. Kamp established and leads the Clinical Materials Services Unit (CMSU) which provides packaging, labeling, distribution, return and destructions services for investigational drugs/devices. Ms. Kamp has served as the Senior Project Manager for numerous clinical studies in a number of neurological conditions. She was the Director of Operations for the Clinical Trials Coordination Center (CTCC), University of Rochester, for 8 years responsible for project and data management, monitoring and administration. She has also participated on the steering committees for a number of trials. Ms. Kamp was the Vice President of Operations, SCIREX Research Centers/Premier Research Group (PRG) a for-profit Contract Research Organization (CRO) for three years, overseeing four fully owned research sites, employing 140 clinic staff engaged in studies for acute pain. Additionally, she was responsible for establishing a fifth clinic with a fully functional OR during her tenure. Ms. Kamp has a primary research interest in: Clinical trial design; simplifying clinical materials (drugs/devices) procurement, packaging, labeling, and distribution; regulatory aspects of conducting international clinical trials; recruitment strategies; and site performance metrics.

• Dworkin RH, Turk DC, Katz NP, Rowbotham MC, Peirce-Sandner S, Cerny I, Clingman CS, Eloff BC, Farrar JT, Kamp C, McDermott MP, Rappaport BA, Sanhai WR. Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION. Pain. 2011 Mar; 152(3 Suppl):S107-15.
  View in: PubMed
• Ravina B, Swearingen C, Elm J, Kamp C, Kieburtz K, Kim SY. Long term understanding of study information in research participants with Parkinson's disease. Parkinsonism Relat Disord. 2010 Jan; 16(1):60-3.
  View in: PubMed
• Dworkin RH, Barbano RL, Tyring SK, Betts RF, McDermott MP, Pennella-Vaughan J, Bennett GJ, Berber E, Gnann JW, Irvine C, Kamp C, Kieburtz K, Max MB, Schmader KE. A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain. 2009 Apr; 142(3):209-17.
  View in: PubMed
• Constantinescu R, Romer M, McDermott MP, Kamp C, Kieburtz K. Impact of pramipexole on the onset of levodopa-related dyskinesias. Mov Disord. 2007 Jul 15; 22(9):1317-9.
  View in: PubMed
• Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004 Jul; 61(7):1044-53.
  View in: PubMed
• Rifai Z, Welle S, Kamp C, Thornton CA. Ragged red fibers in normal aging and inflammatory myopathy. Ann Neurol. 1995 Jan; 37(1):24-9.
  View in: PubMed
• Rifai Z, Kazee AM, Kamp C, Griggs RC. Intranuclear rods in severe congenital nemaline myopathy. Neurology. 1993 Nov; 43(11):2372-7.
  View in: PubMed